Search

Your search keyword '"Treat BR"' showing total 11 results

Search Constraints

Start Over You searched for: Author "Treat BR" Remove constraint Author: "Treat BR"
11 results on '"Treat BR"'

Search Results

1. Correction: Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

2. Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy.

3. Genetic Manipulation of Corynebacterium mastitidis to Better Understand the Ocular Microbiome.

4. Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains.

5. SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization.

6. Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains.

7. Xylose-Inducible Promoter Tools for Pseudomonas Species and Their Use in Implicating a Role for the Type II Secretion System Protein XcpQ in the Inhibition of Corneal Epithelial Wound Closure.

8. Herpes Simplex Virus 1-Specific CD8 + T Cell Priming and Latent Ganglionic Retention Are Shaped by Viral Epitope Promoter Kinetics.

9. Differential Expression of Immune Checkpoint Molecules on CD8 + T Cells Specific for Immunodominant and Subdominant Herpes Simplex Virus 1 Epitopes.

10. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells.

11. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

Catalog

Books, media, physical & digital resources